findmyKOL
Clinical trialNCT02533700UnknownPhase 2Interventional

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

SponsorShandong Provincial HospitalEnrollment106ALK-negative Anaplastic Large Cell LymphomaAngioimmunoblastic T Cell LymphomaEnteropathy Associated T Cell LymphomaHepatosplenic T-cell LymphomaPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedSubcutaneous Panniculitis Like T Cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Fujian Medical University Union Hospital

    Fuzhou, Fujian, China

  • Henan Cancer Hospital

    Zhengzhou, Henan, China

  • Shandong Provincial Hospital

    Jinan, Shandong, China

  • Shanghai Ruijin Hospital

    Shanghai, Shanghai Municipality, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2015
Primary completion
31 May 2019
Completion
31 Dec 2020
Last update posted
10 Mar 2020
Registered enrollment
106
Registry id
NCT02533700

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.